FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

15178911000001103: Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53597301000001115 Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53597401000001111 Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
57363501000001110 Osvaren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
96304601000001113 Osvaren 435mg/235mg tablets (Vifor Fresenius Medical Care Renal Pharma UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Is a Calcium acetate 435mg / Magnesium carbonate heavy 235mg tablets true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has active ingredient Calcium acetate true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has excipient Polyoxyl castor oil false Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Is a Rephoren true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has specific active ingredient Calcium acetate true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has specific active ingredient Magnesium carbonate heavy true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has active ingredient Magnesium carbonate true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) 180 tablet Has AMP True Rephoren 435mg/235mg tablets (Fresenius Medical Care (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start